Steinmetz, S., Wernly, D., Moerenhout, K., Trampuz, A., & Borens, O. (2019). Infection after fracture fixation. EFORT Open Reviews, 4(7), 468–475. https://doi.org/10.1302/2058-5241.4.180093

Article  PubMed  PubMed Central  Google Scholar 

Limoli, D. H., Jones, C. J., & Wozniak, D. J. (2015). Bacterial extracellular polysaccharides in biofilm formation and function. Microbiology Spectrum, 3(3), 3. https://doi.org/10.1128/microbiolspec.MB-0011-2014

Singh, S., Singh, S. K., Chowdhury, I., & Singh, R. (2017). Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. The Open Microbiology Journal, 11, 53–62. https://doi.org/10.2174/1874285801711010053

CAS  Article  PubMed  PubMed Central  Google Scholar 

Sharma, D., Misba, L., & Khan, A. U. (2019). Antibiotics versus biofilm: An emerging battleground in microbial communities. Antimicrobial Resistance & Infection Control., 8(1), 76. https://doi.org/10.1186/s13756-019-0533-3

Article  Google Scholar 

Lebeaux, D., Ghigo, J. M., & Beloin, C. (2014). Biofilm-related infections: Bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiology and Molecular Biology Reviews, 78(3), 510–543. https://doi.org/10.1128/MMBR.00013-14

Article  PubMed  PubMed Central  Google Scholar 

Ventola, C. L. (2015). The antibiotic resistance crisis. Pharmacy and Therapeutics, 40(4), 277–283.

PubMed  PubMed Central  Google Scholar 

Aslam, B., Wang, W., Arshad, M. I., et al. (2018). Antibiotic resistance: A rundown of a global crisis. Infection and Drug Resistance, 11, 1645–1658. https://doi.org/10.2147/IDR.S173867

CAS  Article  PubMed  PubMed Central  Google Scholar 

Dominey-Howes, D., Bajorek, B., Michael, C., Betteridge, B., Iredell, J., & Labbate, M. (2015). Applying the emergency risk management process to tackle the crisis of antibiotic resistance. Frontiers in Microbiology., 6, 927. https://doi.org/10.3389/fmicb.2015.00927

Article  PubMed  PubMed Central  Google Scholar 

Laxminarayan, R., Duse, A., Wattal, C., et al. (2013). Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9

Article  PubMed  Google Scholar 

Gibb, B. P., & Hadjiargyrou, M. (2021). Bacteriophage therapy for bone and joint infections. The Bone & Joint Journal, 103-B(2), 234–244. https://doi.org/10.1302/0301-620X.103B2.BJJ-2020-0452.R2.

Tande, A. J., & Patel, R. (2014). Prosthetic joint infection. Clinical Microbiology Reviews, 27(2), 302–345. https://doi.org/10.1128/CMR.00111-13

CAS  Article  PubMed  PubMed Central  Google Scholar 

Li, B., & Webster, T. J. (2018). Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. Journal of Orthopaedic Research, 36(1), 22–32. https://doi.org/10.1002/jor.23656

Article  PubMed  Google Scholar 

Ribeiro, M., Monteiro, F. J., & Ferraz, M. P. (2012). Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter, 2(4), 176–194. https://doi.org/10.4161/biom.22905

Article  PubMed  PubMed Central  Google Scholar 

Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 6, 25–64. https://doi.org/10.4137/PMC.S14459

Article  PubMed  PubMed Central  Google Scholar 

Otto, M. (2009). Staphylococcus epidermidis—The “accidental” pathogen. Nature Reviews Microbiology, 7(8), 555–567. https://doi.org/10.1038/nrmicro2182

CAS  Article  PubMed  PubMed Central  Google Scholar 

Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 10, 539. https://doi.org/10.3389/fmicb.2019.00539

Article  PubMed  PubMed Central  Google Scholar 

Gandra, S., Tseng, K. K., Arora, A., et al. (2019). The mortality burden of multidrug-resistant pathogens in India: A retrospective, observational study. Clinical Infectious Diseases, 69(4), 563–570. https://doi.org/10.1093/cid/ciy955

Article  PubMed  Google Scholar 

Karaiskos, I., Lagou, S., Pontikis, K., Rapti, V., & Poulakou, G. (2019). The, “Old” and the “New” antibiotics for MDR gram-negative pathogens: For whom, when, and how. Frontiers in Public Health, 7, 151. https://doi.org/10.3389/fpubh.2019.00151

Article  PubMed  PubMed Central  Google Scholar 

Wittebole, X., De Roock, S., & Opal, S. M. (2014). A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence, 5(1), 226–235. https://doi.org/10.4161/viru.25991

Article  PubMed  Google Scholar 

Clokie, M. R., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011). Phages in nature. Bacteriophage., 1(1), 31–45. https://doi.org/10.4161/bact.1.1.14942

Article  PubMed  PubMed Central  Google Scholar 

Doss, J., Culbertson, K., Hahn, D., Camacho, J., & Barekzi, N. (2017). A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses, 9(3), 50. https://doi.org/10.3390/v9030050

CAS  Article  PubMed Central  Google Scholar 

Lin, D. M., Koskella, B., & Lin, H. C. (2017). Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World Journal of Gastrointestinal Pharmacology and Therapeutics, 8(3), 162–173. https://doi.org/10.4292/wjgpt.v8.i3.162

Article  PubMed  PubMed Central  Google Scholar 

Principi, N., Silvestri, E., & Esposito, S. (2019). Advantages and limitations of bacteriophages for the treatment of bacterial infections. Frontiers in Pharmacology, 10, 513. https://doi.org/10.3389/fphar.2019.00513

Article  PubMed  PubMed Central  Google Scholar 

Loc-Carrillo, C., & Abedon, S. T. (2011). Pros and cons of phage therapy. Bacteriophage, 1(2), 111–114. https://doi.org/10.4161/bact.1.2.14590

Article  PubMed  PubMed Central  Google Scholar 

Brady, T. S., Fajardo, C. P., Merrill, B. D., et al. (2018). Bystander phage therapy: Inducing host-associated bacteria to produce antimicrobial toxins against the pathogen using phages. Antibiotics, 7(4), 105. https://doi.org/10.3390/antibiotics7040105

CAS  Article  PubMed Central  Google Scholar 

Rosner, D., & Clark, J. (2021). Formulations for bacteriophage therapy and the potential uses of immobilization. Pharmaceuticals (Basel), 14(4), 359. https://doi.org/10.3390/ph14040359

CAS  Article  Google Scholar 

Rotman, S. G., Sumrall, E., Ziadlou, R., et al. (2020). Local bacteriophage delivery for treatment and prevention of bacterial infections. Frontiers in Microbiology, 11, 538060. https://doi.org/10.3389/fmicb.2020.538060

Article  PubMed  PubMed Central  Google Scholar 

Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001). Bacteriophage therapy. Antimicrobial Agents and Chemotherapy, 45(3), 649–659. https://doi.org/10.1128/AAC.45.3.649-659.2001

CAS  Article  PubMed  PubMed Central  Google Scholar 

Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013). Phage cocktails and the future of phage therapy. Future Microbiology, 8(6), 769–783. https://doi.org/10.2217/fmb.13.47

CAS  Article  PubMed  Google Scholar 

Hyman, P. (2019). Phages for phage therapy: Isolation, characterization, and host range breadth. Pharmaceuticals (Basel), 12(1), 35. https://doi.org/10.3390/ph12010035

CAS  Article  Google Scholar 

Abedon, S. T. (2018). Phage therapy: Various perspectives on how to improve the art. Methods in Molecular Biology, 1734, 113–127. https://doi.org/10.1007/978-1-4939-7604-1_11

CAS  Article  PubMed  Google Scholar 

Gu Liu, C., Green, S. I., Min, L., et al. Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio, 11(4), e01462-20. https://doi.org/10.1128/mBio.01462-20

Zimecki, M., Artym, J., Kocięba, M., Weber-Dąbrowska, B., Borysowski, J., & Górski, A. (2009). Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC Microbiology, 9(1), 169. https://doi.org/10.1186/1471-2180-9-169

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zimecki, M., Artym, J., Kocieba, M., Weber-Dabrowska, B., Borysowski, J., & Górski, A. (2010). Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus. Medical Microbiology and Immunology, 199(2), 71–79. https://doi.org/10.1007/s00430-009-0135-4

Article  PubMed  Google Scholar 

Morris, J., Kelly, N., Elliott, L., et al. (2019). Evaluation of bacteriophage anti-biofilm activity for potential control of orthopedic implant-related infections caused by Staphylococcus aureus. Surgical Infections (Larchmt), 20(1), 16–24. https://doi.org/10.1089/sur.2018.135

Article  Google Scholar 

Wroe, J. A., Johnson, C. T., & García, A. J. (2020). Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo. Journal of Biomedical Materials Research Part A, 108(1), 39–49. https://doi.org/10.1002/jbm.a.36790

CAS  Article  PubMed  Google Scholar 

Yilmaz, C., Colak, M., Yilmaz, B. C., Ersoz, G., Kutateladze, M., & Gozlugol, M. (2013). Bacteriophage therapy in implant-related infections: An experimental study. Journal of Bone and Joint Surgery American Volume, 95(2), 117–125. https://doi.org/10.2106/JBJS.K.01135

Article  PubMed  Google Scholar 

Kaur, S., Harjai, K., & Chhibber, S. (2016). In vivo assessment of phage and linezolid based implant coatings for treatment of methicillin resistant S. aureus (MRSA) mediated orthopaedic device related infections. PLoS One, 11(6), e0157626. https://doi.org/10.1371/journal.pone.0157626

Kishor, C., Mishra, R. R., Saraf, S. K., Kumar, M., Srivastav, A. K., & Nath, G. (2016). Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model. Indian Journal of Medical Research, 143(1), 87–94. https://doi.org/10.4103/0971-5916.178615

Article  PubMed  PubMed Central  Google Scholar 

Meurice, E., Rguiti, E., Brutel, A., et al. (2012). New antibacterial microporous CaP m